{"id":14396,"date":"2016-01-05T10:00:27","date_gmt":"2016-01-05T10:00:27","guid":{"rendered":"https:\/\/www.heartgenetics.com\/news\/beta-capital-backs-heartgenetics-strategy-in-cardiovascular-molecular-diagnostics\/"},"modified":"2016-01-05T10:00:27","modified_gmt":"2016-01-05T10:00:27","slug":"beta-capital-backs-heartgenetics-strategy-in-cardiovascular-molecular-diagnostics","status":"publish","type":"newslist","link":"https:\/\/www.heartgenetics.com\/pt\/news\/beta-capital-backs-heartgenetics-strategy-in-cardiovascular-molecular-diagnostics\/","title":{"rendered":"Beta Capital backs HeartGenetics&#8217; strategy in cardiovascular molecular diagnostics"},"content":{"rendered":"<div class=\"gmail_default\"><span style=\"font-family: verdana, sans-serif;\"><strong>HeartGenetics<\/strong> is happy\u00a0to announce that we have raised a new financing round with <a href=\"http:\/\/www.betacapital.pt\/?sec=home\">Beta Capital<\/a>.\u00a0Beta Capital is a privately held venture capital firm, which invests in innovative, technology-driven companies.<\/span><\/div>\n<div class=\"gmail_default\"><span style=\"font-family: verdana, sans-serif;\">\u00a0<\/span><\/div>\n<div class=\"gmail_default\"><span style=\"font-family: verdana, sans-serif;\"><strong>HeartGenetics<\/strong> will use these new financing to growth its products in genetic molecular diagnostics and expand to new international markets.\u00a0With this capital we will continue to advance HeartGenetics and make improvements to help serve our customers better.<\/span><\/div>\n<div class=\"gmail_default\"><span style=\"font-family: verdana, sans-serif;\">\u00a0<\/span><\/div>\n<div class=\"gmail_default\"><span style=\"color: #494b49; font-family: verdana, sans-serif;\">Learn more about <strong>HeartGenetics<\/strong> products\u00a0and services <a href=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2014\/08\/HeartGenetics-Genetic-Panel2015.10.pdf\">here<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.heartgenetics.com\/products\/\">here<\/a>.\u00a0<\/span><\/div>\n<div class=\"gmail_default\"><\/div>\n<div class=\"gmail_default\"><\/div>\n<div class=\"gmail_default\"><span style=\"color: #494b49; font-family: verdana, sans-serif;\">Learn more about <strong>Beta Capital<\/strong> <a href=\"http:\/\/www.betacapital.pt\">here<\/a>.\u00a0<\/span><\/div>\n<div class=\"gmail_default\"><span style=\"color: #494b49; font-family: verdana, sans-serif;\">\u00a0<\/span><\/div>\n<div class=\"gmail_default\"><span style=\"color: #494b49; font-family: verdana, sans-serif;\">4-1-16\u00a0<\/span><\/div>\n<div class=\"gmail_default\"><\/div>\n<div class=\"gmail_default\"><a href=\"https:\/\/www.heartgenetics.com\/pt\/?page_id=12657\">Older news\u00a0<\/a><\/div>\n","protected":false},"excerpt":{"rendered":"<p>HeartGenetics is happy\u00a0to announce that we have raised a new financing round with Beta Capital.\u00a0Beta Capital is a privately held venture capital firm, which invests [&hellip;]<\/p>\n","protected":false},"featured_media":0,"menu_order":0,"template":"","class_list":["post-14396","newslist","type-newslist","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/newslist\/14396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/newslist"}],"about":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/types\/newslist"}],"version-history":[{"count":0,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/newslist\/14396\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/media?parent=14396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}